![]()
Phenotype Annotations Click to see Annotation Detail View
Mammalian PhenotypeTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | decreased circulating HDL cholesterol level | | IAGP | | 1580751 | compared to BN.PD-D8Rat39-D8Rat35/Cub | RGD | | impaired glucose tolerance | | IAGP | | 1580751 | compared to BN.PD-D8Rat39-D8Rat35/Cub | RGD | | increased circulating LDL cholesterol level | | IAGP | | 1580751 | compared to BN.PD-D8Rat39-D8Rat35/Cub | RGD | | increased circulating triglyceride level | induced | IAGP | XCO:0000211 | 1580751 | compared to BN.PD-D8Rat39-D8Rat35/Cub | RGD | | increased circulating VLDL triglyceride level | induced | IAGP | XCO:0000211 | 1580751 | compared to BN.PD-D8Rat39-D8Rat35/Cub | RGD | | increased epididymal fat pad weight | induced | IAGP | XCO:0000211 | 1580751 | compared to BN.PD-D8Rat39-D8Rat35/Cub | RGD | | increased kidney weight | induced | IAGP | XCO:0000211 | 1580751 | compared to BN.PD-D8Rat39-D8Rat35/Cub | RGD | | increased retroperitoneal fat pad weight | induced | IAGP | XCO:0000211 | 1580751 | compared to BN.PD-D8Rat39-D8Rat35/Cub | RGD | | |